CS188162B2 - Method of producing derivatives of nonapeptide amide - Google Patents

Method of producing derivatives of nonapeptide amide

Info

Publication number
CS188162B2
CS188162B2 CS733045A CS304573A CS188162B2 CS 188162 B2 CS188162 B2 CS 188162B2 CS 733045 A CS733045 A CS 733045A CS 304573 A CS304573 A CS 304573A CS 188162 B2 CS188162 B2 CS 188162B2
Authority
CS
Czechoslovakia
Prior art keywords
producing derivatives
nonapeptide amide
nonapeptide
amide
derivatives
Prior art date
Application number
CS733045A
Other languages
English (en)
Inventor
Masahiko Fujino
Shigeru Kobayashi
Mikihiko Obayashi
Susumu Shinagawa
Tsunehiko Fukuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4268672A external-priority patent/JPS5324423B2/ja
Priority claimed from JP11845272A external-priority patent/JPS5324424B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CS188162B2 publication Critical patent/CS188162B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CS733045A 1972-04-29 1973-04-27 Method of producing derivatives of nonapeptide amide CS188162B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4268672A JPS5324423B2 (cs) 1972-04-29 1972-04-29
JP11845272A JPS5324424B2 (cs) 1972-11-24 1972-11-24

Publications (1)

Publication Number Publication Date
CS188162B2 true CS188162B2 (en) 1979-02-28

Family

ID=26382407

Family Applications (1)

Application Number Title Priority Date Filing Date
CS733045A CS188162B2 (en) 1972-04-29 1973-04-27 Method of producing derivatives of nonapeptide amide

Country Status (17)

Country Link
US (1) US3853837A (cs)
AT (1) AT333988B (cs)
AU (1) AU453931B2 (cs)
CA (1) CA1005815A (cs)
CH (1) CH580065A5 (cs)
CS (1) CS188162B2 (cs)
DE (2) DE2366379C2 (cs)
DK (1) DK147851C (cs)
ES (1) ES414197A1 (cs)
FI (1) FI56676C (cs)
FR (1) FR2183021B1 (cs)
GB (1) GB1403642A (cs)
HU (1) HU168696B (cs)
NL (2) NL176856C (cs)
NO (1) NO139560C (cs)
PL (1) PL95790B1 (cs)
SE (1) SE397520B (cs)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931138A (en) * 1973-03-13 1976-01-06 Abbott Laboratories N-carbobenzoxy-pyroglutamyl-histidine
AT347054B (de) * 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von neuen nonapeptidamid-derivaten
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US4338305A (en) * 1975-03-24 1982-07-06 American Home Products Corporation Use of LRH and LRH agonists
AU497512B2 (en) * 1975-04-15 1978-12-14 Ici Australia Limited Nona and deca-peptides
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides
DE2905502C2 (de) * 1979-02-14 1982-07-15 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
JP2653255B2 (ja) 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
CA2050425A1 (en) 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
NZ240214A (en) 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
EP0582459B1 (en) 1992-08-07 1998-01-07 Takeda Chemical Industries, Ltd. Production of microcapsules of water-soluble drugs
ATE178789T1 (de) * 1994-02-21 1999-04-15 Takeda Chemical Industries Ltd Polyester matrix für eine pharmazeutische zusammensetzung mit verzögerter freigabe
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
EP0813887A3 (en) * 1996-06-20 1999-11-03 Hisamitsu Pharmaceutical Co. Inc. A device structure for iontophoresis
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
JP4414517B2 (ja) 1999-09-01 2010-02-10 久光製薬株式会社 イオントフォレーシス用デバイス構造体
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CA2810477C (en) 2002-12-13 2013-09-17 Durect Corporation Oral drug delivery system
SI2767292T1 (sl) 2004-09-17 2017-01-31 Durect Corporation Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
ES2388355T3 (es) 2006-11-03 2012-10-11 Durect Corporation Sistemas de suministro transdémico que comprenden bupivacaína
EP3326621A1 (en) 2007-12-06 2018-05-30 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
AU2014233453A1 (en) 2013-03-15 2015-10-01 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Also Published As

Publication number Publication date
AT333988B (de) 1976-12-27
DK147851B (da) 1984-12-24
FR2183021B1 (cs) 1976-04-09
PL95790B1 (pl) 1977-11-30
NO139560C (no) 1979-04-04
CH580065A5 (cs) 1976-09-30
CA1005815A (en) 1977-02-22
FI56676B (fi) 1979-11-30
ATA377173A (de) 1976-04-15
AU5467673A (en) 1974-10-17
GB1403642A (en) 1975-08-28
ES414197A1 (es) 1976-05-01
NL7305995A (cs) 1973-10-31
FR2183021A1 (cs) 1973-12-14
NL930004I1 (nl) 1993-04-01
AU453931B2 (en) 1974-10-17
DE2321174C2 (de) 1982-04-15
US3853837A (en) 1974-12-10
HU168696B (cs) 1976-06-28
DE2366379C2 (de) 1985-01-17
NO139560B (no) 1978-12-27
NL176856C (nl) 1985-06-17
DK147851C (da) 1986-03-10
SE397520B (sv) 1977-11-07
DE2321174A1 (de) 1973-11-08
FI56676C (fi) 1980-03-10

Similar Documents

Publication Publication Date Title
CS188162B2 (en) Method of producing derivatives of nonapeptide amide
CS187389B2 (en) Method of producing alkanolamine derivatives
BG32717A3 (en) Method for obtaining of n- organo- n- phosphonomethylglicine- n- oxides
CS182780B2 (en) Method for preparing amides of triiodoisophtaloyl-monoaminoacids
CS183686B2 (en) Method of producing 1-hydroxy-2-pyridones
CS183721B2 (en) Method of production of alfa-aminoacylcephalosporines
CS182234B2 (en) Method of producing n-benzhydryl-n-p-hydroxy-benzylpiperazine
CS192502B2 (en) Method of preparing derivatives of 3-carbamoyl-oxymethyl-cephalosporin
CS191212B2 (en) Method of producing lysergamides
CS192504B2 (en) Method of producing cyano-methyl-thioacetyl-cephalosporins
CS190393B2 (en) Method of producing antibiotic a-2315
BG24661A3 (en) Method of preparing d-1-11-deoxoprostaglandine-e
CS182781B2 (en) Method of producing 2,6-diaminodihydropyridines
CS189620B2 (en) Method of producing vincamine and stereoisomers thereof
CS188175B2 (en) Method of producing 15-substituted omega-nor-prostaglandins
CS183694B2 (en) Method of producing novel alfa-/o-sulphobenzimido/lactams
KR780000255B1 (en) Preparation method of n-(diethalaminoethal)-2-methoxy-5-methylsulphonyl-benzamide
CS187377B2 (en) Method of producing novel cyclohexone derivatives
CS181238B2 (en) Method of preparing 2-benzoyl-3-aminopyridines
CS189616B2 (en) Method of producing basic substituted derivatives of theophyline
CS181731B2 (en) Method of producing new derivatives of 2,10-dichlor-12h-dibenzo/d,g//1,3/dioxocine
CS193022B2 (en) Method of producing derivatives of phosphonourea or phosphonothiourea
JPS51125018A (en) Method of producing teromerized polyamide
CS178903B2 (en) Method of producing urethans
KR780000447B1 (en) Method of producing benzylamine